Use and Outcomes of SARS-COV-2 Monoclonal Antibody Therapy in Patients with Primary Immunodeficiency

被引：0
|
作者：
Monahan, Rose [1 ]
Tang, Monica [1 ]
Pham, Michele [1 ]
机构：
[1] UCSF, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2022年 / 42卷 / SUPPL 1期
关键词：
SARS-CoV-2; Covid-19; monoclonal antibody therapy; REGN-COV2; antibody deficiency;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
146
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [21] Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
    Jaki, Lena
    Weigang, Sebastian
    Kern, Lisa
    Kramme, Stefanie
    Wrobel, Antoni G.
    Grawitz, Andrea B.
    Nawrath, Philipp
    Martin, Stephen R.
    Daehne, Theo
    Beer, Julius
    Disch, Miriam
    Kolb, Philipp
    Gutbrod, Lisa
    Reuter, Sandra
    Warnatz, Klaus
    Schwemmle, Martin
    Gamblin, Steven J.
    Neumann-Haefelin, Elke
    Schnepf, Daniel
    Welte, Thomas
    Kochs, Georg
    Huzly, Daniela
    Panning, Marcus
    Fuchs, Jonas
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [22] Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
    Lena Jaki
    Sebastian Weigang
    Lisa Kern
    Stefanie Kramme
    Antoni G. Wrobel
    Andrea B. Grawitz
    Philipp Nawrath
    Stephen R. Martin
    Theo Dähne
    Julius Beer
    Miriam Disch
    Philipp Kolb
    Lisa Gutbrod
    Sandra Reuter
    Klaus Warnatz
    Martin Schwemmle
    Steven J. Gamblin
    Elke Neumann-Haefelin
    Daniel Schnepf
    Thomas Welte
    Georg Kochs
    Daniela Huzly
    Marcus Panning
    Jonas Fuchs
    Nature Communications, 14
  • [23] An engineered bispecific human monoclonal antibody against SARS-CoV-2
    Zhaohui Li
    Shihua Li
    Gen Zhang
    Weiyu Peng
    Zhen Chang
    Xue Zhang
    Zheng Fan
    Yan Chai
    Feiran Wang
    Xin Zhao
    Dedong Li
    Rong Zhang
    Zhanlong He
    Weiwei Zou
    Ke Xu
    Wenwen Lei
    Peipei Liu
    Junfeng Hao
    Jingjing Zhang
    Litao Sun
    Guizhen Wu
    Shuguang Tan
    George Fu Gao
    Feng Gao
    Yan Wu
    Nature Immunology, 2022, 23 : 423 - 430
  • [24] AAMC Discusses Monoclonal Antibody Therapeutics for SARS-CoV-2 Infection
    Donnenberg, Vera S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (03): : 280 - 281
  • [25] The Impact of SARS-CoV-2 Variant Testing on Monoclonal Antibody Allocation
    Lawong, A.
    SoRelle, J.
    Zhang, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S67 - S68
  • [26] An engineered bispecific human monoclonal antibody against SARS-CoV-2
    Li, Zhaohui
    Li, Shihua
    Zhang, Gen
    Peng, Weiyu
    Chang, Zhen
    Zhang, Xue
    Fan, Zheng
    Chai, Yan
    Wang, Feiran
    Zhao, Xin
    Li, Dedong
    Zhang, Rong
    He, Zhanlong
    Zou, Weiwei
    Xu, Ke
    Lei, Wenwen
    Liu, Peipei
    Hao, Junfeng
    Zhang, Jingjing
    Sun, Litao
    Wu, Guizhen
    Tan, Shuguang
    Gao, George Fu
    Gao, Feng
    Wu, Yan
    NATURE IMMUNOLOGY, 2022, 23 (03) : 423 - +
  • [27] Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection
    Bermejo-Gomez, Amanda
    Aguilera-Alonso, David
    Rincon-Lopez, Elena Maria
    Catalan-Alonso, Pilar
    Bardon-Cancho, Eduardo J.
    Garcia-Morin, Marina
    Manrique-Rodriguez, Silvia
    Navarro-Gomez, Maria Luisa
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (08) : E290 - E292
  • [28] Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients
    Tey, Shu-Farn
    Tsai, Ya-Wen
    Wu, Jheng-Yan
    Liu, Ting-Hui
    Chuang, Min-Hsiang
    Hsu, Wan-Hsuan
    Huang, Po-Yu
    Lai, Chih-Cheng
    Hsu, Chi-Kuei
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [29] T-cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients
    Awuah, Arnold
    Zamani, Ava
    Tahami, Fariba
    Davis, Mark
    Grandjean, Louis
    Buckland, Matthew
    Gilmour, Kimberly
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 207 (03): : 336 - 339
  • [30] Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
    Taha, Yusri
    Wardle, Hayley
    Evans, Adam B.
    Hunter, Ewan R.
    Marr, Helen
    Osborne, Wendy
    Bashton, Matthew
    Smith, Darren
    Burton-Fanning, Shirelle
    Schmid, Matthias L.
    Duncan, Christopher J. A.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)
12345